Marshall Wace LLP Invests $20.47 Million in Azenta, Inc. (NASDAQ:AZTA)

Marshall Wace LLP bought a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 409,376 shares of the company's stock, valued at approximately $20,469,000. Marshall Wace LLP owned about 0.90% of Azenta as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the stock. Picton Mahoney Asset Management raised its stake in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares in the last quarter. Headlands Technologies LLC purchased a new stake in shares of Azenta during the fourth quarter worth $40,000. Covestor Ltd grew its stake in shares of Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after buying an additional 799 shares in the last quarter. KBC Group NV lifted its position in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the last quarter. Finally, Sterling Capital Management LLC grew its stake in Azenta by 39.8% in the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock valued at $143,000 after buying an additional 813 shares during the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Stock Performance

NASDAQ AZTA traded down $0.37 on Friday, hitting $26.77. 137,665 shares of the stock traded hands, compared to its average volume of 643,547. Azenta, Inc. has a 12 month low of $24.06 and a 12 month high of $63.58. The business's fifty day moving average is $35.38 and its two-hundred day moving average is $43.39. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -8.93 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AZTA has been the topic of a number of recent research reports. Needham & Company LLC lifted their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a report on Thursday, February 6th. Evercore ISI boosted their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Finally, Stephens reiterated an "overweight" rating and set a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.